Burcon NutraScience Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Burcon NutraScience Fair Value Forecast for 2023 - 2025 - 2030
Burcon NutraScience's Price has seen impressive growth In the last two years, rising from C$0.00 to C$0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach C$0.00 – an increase of 100.00%. For the next five years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XENE Stock Forecast | Xenon Pharmaceuticals | Buy |
11
|
$40.65 | Buy/Sell | $51.46 | 47.60% |
| ZYME Stock Forecast | Zymeworks | Outperform |
7
|
$8.58 | Buy/Sell | $13.52 | 63.17% |
| AUPH Stock Forecast | Aurinia Pharmaceuticals | Outperform |
6
|
$5.09 | Buy/Sell | $13.21 | 96.46% |
| EPIX Stock Forecast | ESSA Pharma | Buy |
5
|
$6.43 | Buy/Sell | $26.91 | 268.43% |
| ACHF.F Stock Forecast | Arch Biopartners | - |
4
|
$1.12 | Buy/Sell | $0.00 | -100.00% |
Burcon NutraScience Revenue Forecast for 2023 - 2025 - 2030
Burcon NutraScience's Revenue has seen impressive growth In the last three years, rising from C$30.00k to C$360.00k – a growth of 1100.00%. For the following year, the 0 analysts predict that Burcon NutraScience's Revenue will drop by 29.43%, reaching C$254.04k. In 2030, the professionals' prediction is that BU's Revenue will decrease by 21.80%, reaching C$281.53k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRDL Stock Forecast | Cardiol Therapeutics | Outperform |
7
|
C$2.78 | Buy/Sell | C$4.50 | 61.87% |
| SVA Stock Forecast | Sernova | Outperform |
5
|
C$0.42 | Buy/Sell | C$4.07 | 685.71% |
| MIST Stock Forecast | Milestone Pharmaceuticals | Outperform |
4
|
$1.65 | Buy/Sell | $10.80 | 324.24% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDNA Stock Forecast | Medicenna Therapeutics | Buy |
0
|
C$2.32 | Buy/Sell | C$6.30 | 201.72% |
| PMN Stock Forecast | ProMIS Neurosciences | Buy |
6
|
$2.00 | Buy/Sell | $18.49 | 501.00% |
| BCT Stock Forecast | BriaCell Therapeutics | Outperform |
4
|
C$2.96 | Buy/Sell | C$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IPA Stock Forecast | ImmunoPrecise Antibodies | Buy |
9
|
$1.28 | Buy/Sell | $7.00 | 446.88% |
| APS Stock Forecast | Aptose Biosciences | Outperform |
9
|
C$1.69 | Buy/Sell | C$11.08 | -100.00% |
| MBX Stock Forecast | Microbix Biosystems | Buy |
0
|
C$0.43 | Buy/Sell | C$0.00 | 86.05% |
Burcon NutraScience EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Burcon NutraScience's EBITDA has seen an increase, rising from C$-3.69M to C$-7.29M. This represents a growth of 97.56%. According to the 0 analysts polled, in the next year, Burcon NutraScience's EBITDA will fall by 18.59%, reaching C$-5.94M. By 2030, professionals believe that Burcon NutraScience's EBITDA will have decreased by 14.37%, falling to C$-6.24M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IBT Stock Forecast | IBEX Technologies | - |
0
|
C$1.44 | Buy/Sell | C$0.70 | -100.00% |
| TBPM.Q Stock Forecast | Tetra Bio-Pharma | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| COV Stock Forecast | Covalon Technologies | - |
0
|
C$1.01 | Buy/Sell | C$0.00 | -100.00% |
Burcon NutraScience EBIT Forecast for 2023 - 2025 - 2030
Burcon NutraScience's EBIT has seen growth In the last three years, going from C$-3.72M to C$-7.53M – a gain of 102.42% For the next year, 0 analysts project Burcon NutraScience's EBIT to drop by 19.29%, reaching C$-6.08M. By 2030, professionals believe that Burcon NutraScience's EBIT will decrease by 15.10%, reaching C$-6.39M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 20B Stock Forecast | Biomark Diagnostics | - |
0
|
0.17€ | Buy/Sell | 0.00€ | -100.00% |
| SBM Stock Forecast | Sirona Biochem | - |
-10
|
C$0.07 | Buy/Sell | C$0.95 | -100.00% |
| EDSA Stock Forecast | Edesa Biotech | Buy |
-17
|
$4.44 | Buy/Sell | $36.67 | 372.97% |
Burcon NutraScience EPS Price Prediction Forecast for 2023 - 2025 - 2030
Burcon NutraScience's EPS has seen impressive growth In the last two years, rising from C$-0.06 to C$0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach C$0.00 – an increase of 100.00%. For the next five years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RVX Stock Forecast | Resverlogix | - |
0
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
| MVMD Stock Forecast | Mountain Valley MD Holdings | - |
-16
|
C$0.06 | Buy/Sell | C$0.00 | -100.00% |
| KNE Stock Forecast | Kane Biotech | - |
0
|
C$0.12 | Buy/Sell | C$0.00 | -100.00% |
.jpg)